Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
Trial ID or NCT#
NCT06096337
Status
NOT RECRUITING
Purpose
The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation treatment for subjects with persistent atrial fibrillation as compared to subjects who received an initial treatment with anti-arrhythmic drugs.
Official Title
A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation (PFA) Versus Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
Investigator(s)
Alexander C. Perino
Cardiac electrophysiologist
Clinical Associate Professor, Medicine - Cardiovascular Medicine
View on ClinicalTrials.gov
